HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arterial blood pressure and effective peritoneal blood flow during intermittent peritoneal dialysis.

Abstract
Our earlier studies indicate that effective peritoneal blood flow (EPBF) during intermittent peritoneal dialysis (IPD) does not depend on gender, age, body mass, renal disease leading to uremia and duration of IPD. Thus, a cause of differences in EPBF observed in uremic patients during IPD is still not clear. The aim of present studies is an evaluation of relationship between arterial blood pressure and EPBF calculated as diffusive mass transfer coefficient of CO2. Studies were performed in 20 patients in the age of 47 +/- 14 (x +/- SD) years, treated with IPD during 4.3 +/- 3.6 months. EPBF and arterial blood pressure were evaluated in the middle of dialysis. Mean arterial pressure was calculated from systolic and diastolic pressure. In patients (n = 10) with greater EPBF (291 +/- 99 ml/min) systolic, diastolic and mean pressures were respectively 166 +/- 24, 100 +/- 20 and 122 +/- 20 mmHg. In patients (n = 10) with smaller EPBF (154 +/- 27 ml/min) respective pressure were 160 +/- 12, 91 +/- 9 and 114 +/- 8 mmHg. The highest but insignificant correlation was found between EPBF and diastolic blood pressure (r = 0.310, n = 20). Patients with significantly higher diastolic (108 +/- 16 mmHg, n = 9, v. 85 +/- 6 mmHg, n = 11) and mean blood pressure (129 +/- 17 v. 108 +/- 2 mmHg) showed insignificantly greater EPBF (260 +/- 121 v. 192 +/- 63 ml/min). Our studies indicate that EPBF during IPD cannot significantly depend on blood pressure.
AuthorsA Grzegorzewska, I Mariak
JournalPolish journal of pharmacology (Pol J Pharmacol) 1996 Jan-Feb Vol. 48 Issue 1 Pg. 99-103 ISSN: 1230-6002 [Print] Poland
PMID9112636 (Publication Type: Journal Article)
Topics
  • Adult
  • Blood Pressure
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peritoneal Dialysis
  • Peritoneum (blood supply)
  • Uremia (physiopathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: